Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 9,533	$ 33,174
Marketable securities	24,394	7,130
Clearing broker deposits	3,550
Prepaid expenses and other current assets	745	564
Prepaid acquisition cost		301
Short-term investments at fair value	13	13
Notes receivable, at fair value - current portion	6,536	7,474
Investment in Fieldpoint Securities		2,000
Total current assets	44,771	50,656
Property and equipment, net	353
Notes receivable, at fair value - non-current portion	1,850	1,100
Investments	23,103	23,103
Right-of-use assets	3,619	919
Security deposit	458	458
Total assets	74,154	76,236
Current liabilities
Accounts payable and accrued expenses	641	447
Accrued salaries and benefits	732	1,260
Accrued Commissions	25
Lease liability - current	198	82
Other Current liability	124
Total current liabilities	1,720	1,789
Lease liability	3,363	680
Total liabilities	5,083	2,469
Stockholders’ equity
Preferred stock value
Common stock, $0.0001 par value, 100,000,000 shares authorized; 4,815,597 and 5,485,096 shares issued at March 31, 2023 and December 31, 2022, respectively; 4,755,449 and 5,017,079 shares outstanding at March 31, 2023 and December 31, 2022, respectively
Additional paid-in capital	259,215	262,970
Treasury stock, at cost, 60,148 and 468,017 shares at March 31, 2023 and December 31, 2022, respectively	(501)	(3,322)
Accumulated deficit	(189,643)	(185,881)
Total stockholders’ equity	69,071	73,767
Total liabilities and stockholders’ equity	74,154	76,236
Series D Preferred Stock
Stockholders’ equity
Preferred stock value
Series D-1 Preferred Stock
Stockholders’ equity
Preferred stock value